Literature DB >> 24258262

Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion.

Han Zhang1, Shou-Xin Yuan, Shu-Yang Dai, Jin-Min Zhang, Xing Huang, Chong-De Lu, Jun-Hua Lu, Fu-Quan Wu, Wan Yee Lau, Meng-Chao Wu, Tian Yang, Feng Shen.   

Abstract

OBJECTIVE: The aim of this study was to investigate the prognostic value of tumor size alone on long-term survival and recurrence after curative resection for solitary hepatocellular carcinoma (HCC) without macroscopic vascular invasion.
METHODS: A single-center cohort of 615 patients with solitary HCC (a single tumor, without macroscopic vascular invasion or distant metastasis) undergoing curative hepatic resection from 2002 to 2010 was retrospectively studied. Using 2.0, 3.0, 4.0, 5.0, 8.0, and 10.0 cm as cut-off values of tumor size, the overall survival (OS) and recurrence-free survival (RFS) rates were compared between the groups of patients with tumor size up to a certain cut-off value and the groups of patients with tumor size above that cut-off value. Thus, multiple comparisons were done. The prognostic factors of OS and RFS were evaluated using univariate and multivariate analyses.
RESULTS: The median tumor size of all HCCs was 4.0 cm (range 0.9-22.0 cm). The in-hospital mortality rate was 1.0 %, and the overall morbidity rate was 22.3 %. The 1-, 3-, and 5-year OS rates were 96.0, 79.8, and 69.9 %, and the corresponding RFS rates were 83.6, 72.7, and 57.2 %, respectively. On univariate analyses, the 1-, 3-, and 5-year OS and RFS rates were significantly different between the individual two groups of patients as divided by the aforementioned different cut-off values of tumor sizes (all p < 0.05). However, when tumor size was put as a continuous variable into multivariate analysis, it was no longer an independent prognostic factor of OS or RFS after curative resection.
CONCLUSIONS: Tumor size did not independently affect long-term survival and recurrence after curative resection of solitary HCC without macroscopic vascular invasion. Therefore, there is no size limit that precludes hepatic resection for solitary HCC, provided the tumor is resectable.

Entities:  

Mesh:

Year:  2014        PMID: 24258262     DOI: 10.1007/s00268-013-2365-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  41 in total

Review 1.  Management of HCC.

Authors:  Carlos Rodríguez de Lope; Silvia Tremosini; Alejandro Forner; María Reig; Jordi Bruix
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

2.  Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection.

Authors:  Durgatosh Pandey; Kang-Hoe Lee; Chun-Tao Wai; Gajanan Wagholikar; Kai-Chah Tan
Journal:  Ann Surg Oncol       Date:  2007-08-10       Impact factor: 5.344

3.  Prognostic factors of solitary large hepatocellular carcinoma: the importance of differentiation grade.

Authors:  L Zhou; J-A Rui; S-B Wang; S-G Chen; Q Qu
Journal:  Eur J Surg Oncol       Date:  2011-04-29       Impact factor: 4.424

4.  Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter.

Authors:  Ronnie Tung-Ping Poon; Sheung Tat Fan; John Wong
Journal:  J Am Coll Surg       Date:  2002-05       Impact factor: 6.113

Review 5.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

6.  Application of tumor-node-metastasis staging 2002 version in locally advanced hepatocellular carcinoma: is it predictive of surgical outcome?

Authors:  Binkui Li; Yunfei Yuan; Guihua Chen; Liru He; Yaqi Zhang; Jinqing Li; Guohui Li; Wan Yee Lau
Journal:  BMC Cancer       Date:  2010-10-07       Impact factor: 4.430

7.  Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection.

Authors:  Lian-Yue Yang; Feng Fang; Di-Peng Ou; Wei Wu; Zhi-Jun Zeng; Fan Wu
Journal:  Ann Surg       Date:  2009-01       Impact factor: 12.969

8.  Outcomes of hepatic resection for a single large hepatocellular carcinoma.

Authors:  Yong Beom Cho; Kuhn Uk Lee; Hae Won Lee; Eung-Ho Cho; Sung-Hoon Yang; Jai Young Cho; Nam-Joon Yi; Kyung-Suk Suh
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

Review 9.  Safety and efficacy of partial hepatectomy for huge (≥10 cm) hepatocellular carcinoma: a systematic review.

Authors:  Yan-Ming Zhou; Bin Li; Dong-Hui Xu; Jia-Mei Yang
Journal:  Med Sci Monit       Date:  2011-02-25

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  24 in total

1.  Differences in the prognostic value of tumor size on hepatocellular cancer-specific survival stratified by gender in a SEER population-based study.

Authors:  Wenjie Zhang; Kangpeng Jin; Fei Wang; Guangyan Zhangyuan; Weiwei Yu; Yang Liu; Haitian Zhang; Ping Zhang; Beicheng Sun
Journal:  United European Gastroenterol J       Date:  2019-04-24       Impact factor: 4.623

2.  Long-Term Outcome After Resection of Huge Hepatocellular Carcinoma ≥ 10 cm: Single-Institution Experience with 471 Patients.

Authors:  Shin Hwang; Young-Joo Lee; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Sung-Gyu Lee
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

3.  The Impact of Tumor Size on Long-Term Survival Outcomes After Resection of Solitary Hepatocellular Carcinoma: Single-Institution Experience with 2558 Patients.

Authors:  Shin Hwang; Young-Joo Lee; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2015-05-09       Impact factor: 3.452

4.  Subclassification of patients with solitary hepatocellular carcinoma based on post-hepatectomy survival: a large retrospective study.

Authors:  Lei Liu; Qi-Shun Zhang; Ling-Hui Pan; Jian-Hong Zhong; Zhen-Ming Qin; Yan-Yan Wang; Hong-Gui Qin; Wen-Feng Gong; Lu-Nan Qi; Bang-De Xiang; Le-Qun Li
Journal:  Tumour Biol       Date:  2015-11-11

5.  Prognostic Prediction Models for Resection of Large Hepatocellular Carcinoma: A Korean Multicenter Study.

Authors:  Shin Hwang; Jae-Won Joh; Hee Jung Wang; Dong Goo Kim; Kyung Sik Kim; Kyung-Suk Suh; Seong Hoon Kim; Hee Chul Yu; Chol Kyoon Cho; Young-Joo Lee; Ki-Hun Kim; Jong Man Kim; Bong-Wan Kim; Sung-Gyu Lee
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

6.  Multiplication of Tumor Volume by Two Tumor Markers Is a Post-Resection Prognostic Predictor for Solitary Hepatocellular Carcinoma.

Authors:  Shin Hwang; Gi-Won Song; Young-Joo Lee; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Dong-Hwan Jung; Gil-Chun Park; Sung-Gyu Lee
Journal:  J Gastrointest Surg       Date:  2016-06-16       Impact factor: 3.452

Review 7.  Controversies and evidence of hepatic resection for hepatocellular carcinoma.

Authors:  Jian-Hong Zhong; Guido Torzilli; Hao Xing; Chao Li; Jun Han; Lei Liang; Han Zhang; Shu-Yang Dai; Le-Qun Li; Feng Shen; Tian Yang
Journal:  BBA Clin       Date:  2016-10-11

8.  Nomograms to Predict the Individual Survival of Patients with Solitary Hepatocellular Carcinoma after Hepatectomy.

Authors:  Junyi Shen; Linye He; Chuan Li; Tianfu Wen; Weixia Chen; Changli Lu; Lvnan Yan; Bo Li; Jiayin Yang
Journal:  Gut Liver       Date:  2017-09-15       Impact factor: 4.519

9.  Optimizing stage of single large hepatocellular carcinoma: A study with subgroup analysis by tumor diameter.

Authors:  Jian-Hong Zhong; Ling-Hui Pan; Yan-Yan Wang; Alessandro Cucchetti; Tian Yang; Xue-Mei You; Liang Ma; Wen-Feng Gong; Bang-De Xiang; Ning-Fu Peng; Fei-Xiang Wu; Le-Qun Li
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

10.  Validation of prognostic impact of ADV score for resection of hepatocellular carcinoma: analysis using Korea Liver Cancer Registry Database.

Authors:  Gil-Chun Park; Shin Hwang; Yo-Han Park; Jin-Uk Choi
Journal:  Ann Surg Treat Res       Date:  2020-04-28       Impact factor: 1.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.